drug · small molecule
IDOSE TR
updated 3mo agoby $GKOS GLAUKOS Corp🔗 ChEMBL
community read0 votes
🐶 often sniffed alongside
top 5Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 2 investigational indications.
targets
Prostaglandin F2-alpha receptor
all catalysts(0)
nothing on the calendar yet
Trials studying IDOSE TR
- phase4Travoprost Intraocular Implant + iStent Infinite
- phase3Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
- phase3Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
- —Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
- phase4Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone
- phase4Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma
- phase2A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)
- phase3Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 35m ago
Found something off?
comments(0)
5-min edit window · permanent after that